TEM

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.

Tempus AI, Inc. (TEM) is a healthcare company listed on Nasdaq, traded in USD. Over the past year it moved between $40.77 and $90.53. The 18 analysts covering it say Buy, with an average price target of $75.06. Its next earnings report is on November 2, 2026.

• Healthcare
• Health Information Services
• Chicago, United States
• 3.8K employees
• Led by Eric P. Lefkofsky J.D.